Zarah (Watson Pharma, Inc.)
Welcome to the PulseAid listing for the Zarah drug offered from Watson Pharma, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Watson Pharma, Inc. |
| NON-PROPRIETARY NAME: | Drospirenone and Ethinyl Estradiol |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2010-09-07 |
| END MARKETING DATE: | 0000-00-00 |
Zarah HUMAN PRESCRIPTION DRUG Details:
| Item Description | Zarah from Watson Pharma, Inc. |
| LABELER NAME: | Watson Pharma, Inc. |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2010-09-07 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 52544-981_7e982cbe-80c5-4a16-8077-25bf915cb718 |
| PRODUCT NDC: | 52544-981 |
| APPLICATION NUMBER: | ANDA090081 |